Medtronic to buy Contego Medical for $380M
Medtronic said Monday it will acquire Raleigh, North Carolina-based Contego Medical in a $380 million deal that aims to expand the Minnesota company's stroke-prevention and blood-clot removal portfolio.[1]
The all-cash transaction will add Contego's embolic protection and thrombectomy technologies to Medtronic's neurovascular and cardiovascular lines, strengthening its position in devices designed to prevent stroke during vascular procedures.[1]
Contego Medical, founded in Raleigh as a specialist in devices that filter or remove dangerous clots and debris from the bloodstream, has built a niche around technologies that try to reduce the risk of stroke in interventions such as carotid artery and other vascular procedures. Its products are designed to capture embolic material in real time, a capability Medtronic has been seeking to bolster as competition intensifies in the fast-growing neurovascular and structural heart markets.[1]
Medtronic, headquartered in the Twin Cities suburb of Fridley, has been reshaping its portfolio around higher-growth therapies, with particular emphasis on stroke care and minimally invasive cardiovascular treatments. The Contego deal fits that strategy by giving Medtronic additional tools for both preventing strokes before they happen and improving outcomes when blood clots do occur, and it underscores the medical device giant's continued use of targeted acquisitions to deepen key technology platforms rather than diversify into unrelated areas.[1]
Show source details & analysis (1 source)
📌 Key Facts
- Medtronic will acquire Contego Medical for $380 million.
- Contego Medical is based in Raleigh, North Carolina.
- The acquisition adds stroke‑prevention and blood‑clot removal technologies to Medtronic’s portfolio.
📰 Source Timeline (1)
Follow how coverage of this story developed over time